abanoquil has been researched along with papaverine in 2 studies
Studies (abanoquil) | Trials (abanoquil) | Recent Studies (post-2010) (abanoquil) | Studies (papaverine) | Trials (papaverine) | Recent Studies (post-2010) (papaverine) |
---|---|---|---|---|---|
22 | 5 | 0 | 6,027 | 305 | 355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Giraldi, A; Wagner, G; Wyllie, M | 1 |
2 other study(ies) available for abanoquil and papaverine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Abanoquil, a new alpha-1 adrenoceptor antagonist. In vitro and in vivo effect on erectile tissue.
Topics: Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Macaca fascicularis; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Papaverine; Penile Erection; Penis; Swine; Tetrahydroisoquinolines | 2000 |